• 1. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 4. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Recent Advances in the Application of Methyl[2-(pyridin-3-yl)ethyl]amine (CAS: 19690-13-2) in Chemical Biology and Pharmaceutical Research

Methyl[2-(pyridin-3-yl)ethyl]amine (CAS: 19690-13-2) is a versatile chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its pyridine and amine functional groups, serves as a crucial building block in the synthesis of various bioactive molecules. Recent studies have explored its potential applications in drug discovery, particularly in the development of novel therapeutic agents targeting neurological disorders, cancer, and infectious diseases. The unique structural features of methyl[2-(pyridin-3-yl)ethyl]amine enable it to interact with a wide range of biological targets, making it a valuable tool for medicinal chemists.

One of the most notable advancements in the use of methyl[2-(pyridin-3-yl)ethyl]amine is its incorporation into the design of small-molecule inhibitors for protein kinases. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibited potent inhibitory activity against specific kinase targets involved in cancer cell proliferation. The researchers utilized structure-activity relationship (SAR) analysis to optimize the compound's binding affinity and selectivity, resulting in promising preclinical candidates. These findings highlight the potential of methyl[2-(pyridin-3-yl)ethyl]amine as a scaffold for developing next-generation kinase inhibitors.

In addition to its role in kinase inhibition, methyl[2-(pyridin-3-yl)ethyl]amine has been investigated for its application in neuropharmacology. A recent study in ACS Chemical Neuroscience reported that this compound could serve as a precursor for the synthesis of ligands targeting nicotinic acetylcholine receptors (nAChRs). These receptors play a critical role in cognitive function and are implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's. The study revealed that methyl[2-(pyridin-3-yl)ethyl]amine-based ligands exhibited high affinity and selectivity for specific nAChR subtypes, offering a potential avenue for developing novel therapeutics for neurological disorders.

Furthermore, the compound's utility extends to the field of antimicrobial research. A 2022 publication in Bioorganic & Medicinal Chemistry Letters described the synthesis of methyl[2-(pyridin-3-yl)ethyl]amine-derived compounds with potent antibacterial activity against drug-resistant strains. The researchers attributed this activity to the compound's ability to disrupt bacterial cell membrane integrity and inhibit essential enzymatic processes. These findings underscore the potential of methyl[2-(pyridin-3-yl)ethyl]amine as a starting point for developing new antibiotics to address the growing threat of antimicrobial resistance.

Despite these promising developments, challenges remain in the optimization and clinical translation of methyl[2-(pyridin-3-yl)ethyl]amine-based compounds. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed through further research. However, the compound's versatility and demonstrated efficacy in various biological contexts make it a compelling subject for ongoing investigation. Future studies are expected to explore its applications in other therapeutic areas, such as immunology and cardiovascular diseases, further expanding its impact on pharmaceutical research.

In conclusion, methyl[2-(pyridin-3-yl)ethyl]amine (CAS: 19690-13-2) represents a valuable chemical entity with diverse applications in drug discovery and chemical biology. Recent studies have highlighted its potential in kinase inhibition, neuropharmacology, and antimicrobial research, paving the way for the development of novel therapeutics. As research continues to uncover new insights into its biological interactions and therapeutic potential, this compound is poised to play an increasingly important role in addressing unmet medical needs.

• 55496-55-4(methyl2-(pyridin-4-yl)ethylamine)
• 84359-16-0(3-(2-Aminoethyl)pyridine hydrochloride)
• 20173-24-4(2-(Pyridin-3-yl)ethylamine)
• 307496-23-7(3-Pyridineethanamine,hydrobromide (1:2))
• 1003561-87-2(methyl[2-(pyridin-3-yl)ethyl]amine dihydrochloride)
• 3000-74-6(N-Methyl-3-pyridinebutanamine)
• 228271-47-4(5H,6H,7H,8H,9H-pyrido[3,4-d]azepine)
• 5415-00-9((N-[2-(pyridin-3-yl)ethyl]butan-1-amine ))
• 1017125-18-6(N,α-DiMethyl-3-pyridineethanaMine)
• 1236791-61-9(3-(azetidin-3-yl)pyridine;dihydrochloride)